uniQure NV logo

uniQure NV

FRA:UQ1 (Netherlands)  
€ 4.79 (+1.27%) Mar 27
At Loss
P/B:
1.23
Market Cap:
€ 238.93M ($ 257.66M)
Enterprise V:
€ -203.73M ($ -219.70M)
Volume:
-
Avg Vol (2M):
1.01K
Also Trade In:
Volume:
-
At Loss
Avg Vol (2M):
1.01K

Business Description

Description
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 4.46
Equity-to-Asset 0.25
Debt-to-Equity 0.67
Debt-to-EBITDA -0.55
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.45
Distress
Grey
Safe
Beneish M-Score -3.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.88
9-Day RSI 54
14-Day RSI 49.58
6-1 Month Momentum % -13.13
12-1 Month Momentum % -69.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.85
Quick Ratio 8.68
Cash Ratio 8.39
Days Inventory 280.1
Days Sales Outstanding 1454.03
Days Payable 221.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.2
Shareholder Yield % -0.28

Financials (Next Earnings Date:2024-05-09 Est.)

FRA:UQ1's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

uniQure NV Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 14.662
EPS (TTM) (€) -6.016
Beta 0.65
Volatility % 59.16
14-Day RSI 49.58
14-Day ATR (€) 0.157797
20-Day SMA (€) 4.67325
12-1 Month Momentum % -69.09
52-Week Range (€) 4.225 - 20.05
Shares Outstanding (Mil) 47.84

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

uniQure NV Filings

Filing Date Document Date Form
No Filing Data

uniQure NV Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

uniQure NV Frequently Asked Questions

What is uniQure NV(FRA:UQ1)'s stock price today?
The current price of FRA:UQ1 is €4.79. The 52 week high of FRA:UQ1 is €20.05 and 52 week low is €4.22.
When is next earnings date of uniQure NV(FRA:UQ1)?
The next earnings date of uniQure NV(FRA:UQ1) is 2024-05-09 Est..
Does uniQure NV(FRA:UQ1) pay dividends? If so, how much?
uniQure NV(FRA:UQ1) does not pay dividend.

Press Release

Subject Date
No Press Release